卡巴拉汀与运动功能受损
Rivastigmin and impaired motor function.
作者信息
Heinze M, Andreae D, Grohmann R
机构信息
Department of Psychiatry and Psychotherapy, Landesklinik Teupitz, Teupitz, Germany.
出版信息
Pharmacopsychiatry. 2002 Mar;35(2):79-80. doi: 10.1055/s-2002-25024.
PMID:11951151
Abstract
In this case study, we describe the case of an 88-year-old female patient diagnosed with Alzheimer's disease who developed a severe motor dysfunction as a side effect of rivastigmin treatment. There have been reports on motor dysfunctions caused by other choline esterase inhibitors.
摘要
在本病例研究中，我们描述了一名88岁被诊断患有阿尔茨海默病的女性患者，她在接受卡巴拉汀治疗时出现了严重的运动功能障碍作为副作用。此前已有关于其他胆碱酯酶抑制剂引起运动功能障碍的报道。
Zotero 插件